News & Analysis as of

American Cancer Society Pharmaceutical Industry

Foley & Lardner LLP

FDA Approves Companion Dx for PD-1 Inhibitor

Foley & Lardner LLP on

According to the American Cancer Society (“ACS”), lung cancer (both small cell and non-small cell) is the second most common cancer in both men and women (not counting skin cancer). About 14% of all new cancers are lung...more

Patrick Malone & Associates P.C. | DC Injury...

When politicians, investors talk big about fighting cancer, hope and be wary

One of the nation’s leading killers has gotten some sky-high attention in recent days. But what to make of President Obama’s proposal for a “moon shot” initiative, led by Vice President Biden, to beat cancer? What to think of...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide